M2D2, the Massachusetts Medical Device Development Center, is an established incubator for medical device and biotechnology companies.
M2D2 is a joint initiative of the Lowell and Worcester campuses of the UMass system. Its aim is to help new biotech and medical device entrepreneurs develop products every step of the way, from proof-of-concept to commercialization. Its affiliated faculty and staff have has assisted more than 100 start-up companies and entrepreneurs since the program kicked off in the spring of 2007.
About T1D Exchange
T1D Exchange is recognized leader in global medical and research community.
Despite many advances in the treatment of type 1 diabetes, most patients struggle to meet recommended HbA1c goals, insulin replacement is still the only effective treatment and living with the condition remains a tremendous quality-of-life and financial burden.
T1D Exchange was born out of the need to build a dynamic, multi-purpose, real-world patient data platform that provides researchers seamless access to aggregated clinical, biological, patient-reported outcomes and electronic health record data, all while fostering collaboration among patients, physicians, researchers and industry. The goal is to speed the research process and direct novel treatments and clinical care that will meet unmet needs in type 1 diabetes (T1D). T1D Exchange has completed several intervention studies and has helped successfully accelerate a new formulation of glucagon into a potentially game-changing approach to the treatment of severe hypoglycemia.